Who owns EFFECTOR THERAPEUTICS INC?
- Ticker: EFTRW
- CUSIP Number: 28202v116
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Aristeia Capital | 1.3M | $184k | -11% | Mar 2024 |
|
| Goldman Sachs Group | 631k | $85k | 0% | Mar 2024 |
|
| Whitebox Advisors | 298k | $40k | 0% | Mar 2024 |
|
| MMCAP International Inc. SPC | 146k | $20k | 0% | Mar 2024 |
|
| Parallel Advisors | 64k | $8.7k | 0% | Mar 2024 |
|
| Millennium Management | 56k | $7.6k | 0% | Mar 2024 |
|
| III Capital Management | 42k | $5.8k | 0% | Mar 2024 |
|
| Tenor Capital Management | 33k | $4.5M | 0% | Mar 2024 |
|
| Sea Otter Advisors | 25k | $3.4k | 0% | Mar 2024 |
|
| Susquehanna International | 17k | $2.4k | 100% | Mar 2024 |
|
| Littlejohn & Co | 17k | $2.3k | 0% | Mar 2024 |
|
| Wolverine Asset Management | 9.8k | $1.3k | -44% | Mar 2024 |
|
| UBS Group | 644.00 | $87.004400 | -55% | Mar 2024 |
|
| Pineridge Advisors | 33.00 | $3.999600 | 0% | Mar 2024 |
|
| Tower Research Capital | 23.00 | $2.999200 | 0% | Mar 2024 |
|